{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:57:02Z","timestamp":1783612622029,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T00:00:00Z","timestamp":1439510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00540-015-2063-3","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T08:48:08Z","timestamp":1439455688000},"page":"166-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of carbamazepine or phenytoin therapy on blood level of intravenously administered midazolam: a prospective cohort study"],"prefix":"10.1007","volume":"30","author":[{"given":"Tomoko","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Tomoyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Ishii-Maruhama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"key":"2063_CR1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0952-8180(91)90203-Y","volume":"3","author":"PF White","year":"1991","unstructured":"White PF, Negus JB. Sedative infusions during local and regional anesthesia: a comparison of midazolam and propofol. J Clin Anesth. 1991;3:32\u20139.","journal-title":"J Clin Anesth"},{"key":"2063_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yebeh.2006.04.001","volume":"9","author":"W Blarikom van","year":"2006","unstructured":"van Blarikom W, Tan IY, Aldenkamp AP, van Gennep AT. Epilepsy, intellectual disability, and living environment: a critical review. Epilepsy Behav. 2006;9:14\u20138.","journal-title":"Epilepsy Behav"},{"key":"2063_CR3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1528-1157.2002.043s2037.x","volume":"43 Suppl 2","author":"E Spina","year":"2002","unstructured":"Spina E, Perucca E. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia. 2002;43 Suppl 2:37\u201344.","journal-title":"Epilepsia"},{"key":"2063_CR4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.clinthera.2008.08.011","volume":"30","author":"KY Yap","year":"2008","unstructured":"Yap KY, Chui WK, Chan A. Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther. 2008;30:1385\u2013407.","journal-title":"Clin Ther"},{"key":"2063_CR5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015910792246254","volume":"8","author":"SI Johannessen","year":"2010","unstructured":"Johannessen SI, Landmark CJ. Antiepileptic drug interactions\u2014principles and clinical implications. Curr Neuropharmacol. 2010;8:254\u201367.","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"2063_CR6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/jcph.446","volume":"55","author":"A Stockis","year":"2015","unstructured":"Stockis A, Watanabe S, Scheen AJ. Effect of brivaracetam on CYP3A activity, measured by oral midazolam. J Clin Pharmacol. 2015;55(5):543\u20138.","journal-title":"J Clin Pharmacol"},{"key":"2063_CR7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1528-1157.1996.tb00021.x","volume":"37","author":"JT Backman","year":"1996","unstructured":"Backman JT, Olkkola KT, Ojala M, Laaksovirta H, Neuvonen PJ. Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin. Epilepsia. 1996;37:253\u20137.","journal-title":"Epilepsia."},{"key":"2063_CR8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00540-011-1176-6","volume":"25","author":"J Ohmori","year":"2011","unstructured":"Ohmori J, Maeda S, Higuchi H, Ishii M, Arai Y, Tomoyasu Y, Kohjitani A, Shimada M, Miyawaki T. Propofol increases the rate of albumin-unbound free midazolam in serum albumin solution. J Anesth. 2011;25:618\u201320.","journal-title":"J Anesth."},{"key":"2063_CR9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/08982104.2010.498002","volume":"21","author":"Y Tomoyasu","year":"2011","unstructured":"Tomoyasu Y, Yasuda T, Maeda S, Higuchi H, Miyawaki T. Liposome-encapsulated midazolam for oral administration. J Liposome Res. 2011;21:166\u201372.","journal-title":"J Liposome Res"},{"key":"2063_CR10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.0306-5251.2001.01474.x","volume":"52","author":"X Wen","year":"2001","unstructured":"Wen X, Wang JS, Kivisto KT, Neuvonen PJ, Backman JT. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9). Br J Clin Pharmacol. 2001;52:547\u201353.","journal-title":"Br J Clin Pharmacol"},{"key":"2063_CR11","first-page":"750","volume":"25","author":"RW Nims","year":"1997","unstructured":"Nims RW, Prough RA, Jones CR, Stockus DL, Dragnev KH, Thomas PE, Lubet RA. In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam. Drug Metab Dispos. 1997;25:750\u20136.","journal-title":"Drug Metab Dispos"},{"key":"2063_CR12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1528-1167.2007.00983.x","volume":"48","author":"G Sills","year":"2007","unstructured":"Sills G, Brodie M. Pharmacokinetics and drug interactions with zonisamide. Epilepsia. 2007;48:435\u201341.","journal-title":"Epilepsia."},{"key":"2063_CR13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/j.1875-9114.2012.01028.x","volume":"32","author":"M Walzer","year":"2012","unstructured":"Walzer M, Bekersky I, Blum RA, Tolbert D. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes. Pharmacotherapy. 2012;32:340\u201353.","journal-title":"Pharmacotherapy."},{"key":"2063_CR14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0749-0704(18)30041-1","volume":"11","author":"J Barr","year":"1995","unstructured":"Barr J, Donner A. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit. Crit Care Clin. 1995;11:827\u201347.","journal-title":"Crit Care Clin"},{"key":"2063_CR15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.gie.2008.09.033","volume":"69","author":"B Hayee","year":"2009","unstructured":"Hayee B, Dunn J, Loganayagam A, Wong M, Saxena V, Rowbotham D, McNair A. Midazolam with meperidine or fentanyl for colonoscopy: results of a randomized trial. Gastrointest Endosc. 2009;69:681\u20137.","journal-title":"Gastrointest Endosc"},{"key":"2063_CR16","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.joms.2010.09.005","volume":"69","author":"O Goktay","year":"2011","unstructured":"Goktay O, Satilmis T, Garip H, Gonul O, Goker K. A comparison of the effects of midazolam\/fentanyl and midazolam\/tramadol for conscious intravenous sedation during third molar extraction. J Oral Maxillofac Surg. 2011;69:1594\u20139.","journal-title":"J Oral Maxillofac Surg"},{"key":"2063_CR17","unstructured":"US FDA. Guidance for industry: population pharmacokinetics. 2015. http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM072137.pdf . Accessed 6 July 2015."},{"key":"2063_CR18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/cp.1999.v66.100038001","volume":"66","author":"N Hamaoka","year":"1999","unstructured":"Hamaoka N, Oda Y, Hase I, Mizutani K, Nakamoto T, Ishizaki T, Asada A. Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study. Clin Pharmacol Ther. 1999;66:110\u20137.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-015-2063-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00540-015-2063-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-015-2063-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T05:53:34Z","timestamp":1567058014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00540-015-2063-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["2063"],"URL":"https:\/\/doi.org\/10.1007\/s00540-015-2063-3","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]}}}